These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 17455416)
21. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India. Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407 [TBL] [Abstract][Full Text] [Related]
22. Management of multi drug resistance tuberculosis in the field: Tuberculosis Research Centre experience. Thomas A; Ramachandran R; Rehaman F; Jaggarajamma K; Santha T; Selvakumar N; Krishnan N; Mohan NS; Sundaram V; Wares F; Narayanan PR Indian J Tuberc; 2007 Jul; 54(3):117-24. PubMed ID: 17886699 [TBL] [Abstract][Full Text] [Related]
23. Do we have evidence for policy changes in the treatment of children with latent tuberculosis infection? Lobato MN; Jereb JA; Castro KG Pediatrics; 2009 Mar; 123(3):902-3. PubMed ID: 19255018 [No Abstract] [Full Text] [Related]
24. Database study of antibiotic resistant tuberculosis in the United Kingdom, 1994-6. Irish C; Herbert J; Bennett D; Gilham C; Drobniewski F; Williams R; Smith EG; Magee JG; Watt B; Chadwick M; Watson JM BMJ; 1999 Feb; 318(7182):497-8. PubMed ID: 10024255 [No Abstract] [Full Text] [Related]
26. Isoniazid resistant TB and non-compliance. van Altena R; van Soolingen D; van der Werf TS Thorax; 2004 Dec; 59(12):1098; author reply 1098-9. PubMed ID: 15563712 [No Abstract] [Full Text] [Related]
27. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance. Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897 [TBL] [Abstract][Full Text] [Related]
28. Declining prevalence of drug-resistant tuberculosis among HIV/tuberculosis co-infected patients receiving antiretroviral therapy. Sungkanuparph S; Eampokalap B; Chottanapund S; Bed ST; Manosuthi W J Med Assoc Thai; 2007 May; 90(5):884-8. PubMed ID: 17596041 [TBL] [Abstract][Full Text] [Related]
29. XDR-TB: Indian perspective. Singh A Eur Respir J; 2007 Jul; 30(1):178-9. PubMed ID: 17601976 [No Abstract] [Full Text] [Related]
30. The impact of drug resistance on the global tuberculosis epidemic. Schluger NW Int J Tuberc Lung Dis; 2000 Feb; 4(2 Suppl 1):S71-5. PubMed ID: 10688153 [No Abstract] [Full Text] [Related]
31. Nationwide survey on the prevalence of anti-tuberculosis drug resistance in the Republic of Yemen, 2004. Al-Akhali A; Ohkado A; Fujiki A; Mitarai S; Yamada N; Masui T; Otomo K; Yamada H; Seita A; Mori T; Al-Absi AN Int J Tuberc Lung Dis; 2007 Dec; 11(12):1328-33. PubMed ID: 18034954 [TBL] [Abstract][Full Text] [Related]
32. Isoniazid-monoresistant tuberculosis in the United States, 1993 to 2003. Hoopes AJ; Kammerer JS; Harrington TA; Ijaz K; Armstrong LR Arch Intern Med; 2008 Oct; 168(18):1984-92. PubMed ID: 18852399 [TBL] [Abstract][Full Text] [Related]
34. TB surveillance in correctional institutions in Hong Kong, 1999-2005. Wong MY; Leung CC; Tam CM; Kam KM; Ma CH; Au KF Int J Tuberc Lung Dis; 2008 Jan; 12(1):93-8. PubMed ID: 18173884 [TBL] [Abstract][Full Text] [Related]
35. Radiometric vs. agar proportion methods for assessing ethionamide resistance and its clinical effects in multidrug-resistant tuberculosis. Cimen NO; Arslan Z; Saygi A; Ocak K; Babacan F; Kurutepe M Int J Tuberc Lung Dis; 2009 Jul; 13(7):907-13. PubMed ID: 19555543 [TBL] [Abstract][Full Text] [Related]